Table 2.
Exposure to immunosuppressants before diagnosis of PCP.
| Immunosuppressants | N = 50 |
|---|---|
| CTX | 24 (48%) |
| CsA | 10 (20%) |
| MMF | 4 (8%) |
| FK506 | 2 (4%) |
| MTX | 1 (2%) |
| TwHF | 1 (2%) |
| LEF | 1 (2%) |
| CTX + CsA | 3 (6%) |
| CTX + TwHF | 2 (4%) |
| CTX + MMF | 1 (2%) |
| CTX + HCQ | 1 (2%) |
CTX: cyclophosphamide, CsA: cyclosporine A, MMF: mycophenolate mofetil, FK506: tacrolimus, MTX: methotrexate, TwHF: tripterygium wilfordii hook F, LEF: leflunomide, and HCQ: hydroxychloroquine. Data were presented as numbers (%).